InvestorsHub Logo
Followers 1
Posts 234
Boards Moderated 0
Alias Born 01/18/2022

Re: A deleted message

Sunday, 05/01/2022 8:04:50 AM

Sunday, May 01, 2022 8:04:50 AM

Post# of 2015
5.8 million Americans were living with Alzheimer's disease. Younger people may get Alzheimer's disease, but it is less common. The number of people living with the disease doubles every 5 years beyond age 65. So you are telling me a drug that services rare skin conditions has more potential then a Alzheimer's drug? May I add the same drug they are using for Alzheimer's also is being tested for simultaneously Bi-Polar disorder, Bipolar disorder (manic-depressive illness) is a neurobiological brain disorder that affects approximately 2.3 million Americans today, or almost 1 percent of the population. Depression, Depression is a common illness worldwide, with an estimated 3.8% of the population affected, including 5.0% among adults and 5.7% among adults older than 60 years . Approximately 280 million people in the world have depression. And Post Traumatic Stress Disorder, Estimated 310 million people suffer from PTSD. So you are telling me a drug that services a rare skin condition has more potential then AZLNs AL001? I find that interesting. But anyway thanks for your opinion very valuable!! NILE
Below is ALZN website
https://alzamend.com/pipeline/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AULT News